Markets:

Overview

News

Currencies

International

Treasuries

Regeneron Pharmaceuticals (NQ:REGN)

634.48 -8.11 (-1.26%)

Streaming Delayed Price Updated: 1:29 PM EDT, May 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Regeneron Pharmaceuticals

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

62 63 Next >

75th Annual Regeneron International Science and Engineering Fair Awards Teen Scientists from Around the World More Than $9 Million in 2025 Competition

May 16, 2025

From Regeneron Pharmaceuticals, Inc.

Via GlobeNewswire

1 Nasdaq 100 Stock with Exciting Potential and 2 to Think Twice About

May 16, 2025

While the Nasdaq 100 (^NDX) is filled with cutting-edge technology and consumer companies, not all are on solid footing. Some are dealing with declining demand, high costs, or regulatory pressures that...

Via StockStory

Regeneron Prevails over Amgen in Antitrust PCSK9 Lawsuit Protecting Biotech Innovation and Patient Access to Life-Saving Treatments

May 15, 2025

From Regeneron Pharmaceuticals, Inc.

Via GlobeNewswire

Big Dippers: 3 Stocks Near 1-Year Lows That Could Surge in 2025

May 15, 2025

CCOI, AESI, and REGN are near one-year lows but remain favored by analysts; watch these stocks for future growth potential.

Via MarketBeat

Topics Government World Trade

Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030 ↗

May 14, 2025

Sanofi plans $20 billion US investment by 2030 to expand R&D and manufacturing, aiming to boost medicine production and job creation across states.

Via Benzinga

Beyond The Numbers: 16 Analysts Discuss Regeneron Pharmaceuticals Stock ↗

May 14, 2025

Via Benzinga

Only Half Of S&P 500 Stocks Joined The Tariff-Relief Rally: Time To Buy The Laggards? ↗

May 14, 2025

Only about 50% of S&P 500 stocks trade above their 200-day average, signaling narrow breadth even as the index rallies 22% since April.

Via Benzinga

Topics Stocks

This PVH Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday ↗

May 14, 2025

Via Benzinga

Best Biotech Stocks to Buy in 2025

May 13, 2025

Discover the best biotech stocks of 2025, including top performers like Vertex and Regeneron, driven by clinical breakthroughs and strong investor momentum.

Via MarketBeat

Topics ETFs Economy Government

REGN Q1 Earnings Call: Pipeline Progress and EYLEA Headwinds Dominate Discussion

May 13, 2025

Biotech company Regeneron (NASDAQ:REGN) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 3.7% year on year to $3.03 billion. Its non-GAAP profit of $8.22 per share was 3%...

Via StockStory

Cathie Wood Says AI Innovation In Healthcare Will Be More 'Profound' Than Autonomous Taxi Networks, Humanoid Robots ↗

May 12, 2025

Cathie Wood highlights the rising applications of AI and how it is poised to impact the health care space.

Via Benzinga

Topics Artificial Intelligence

Trump's New Drug Pricing Executive Order Could Rattle Pharma Stocks, With Price Cuts Of Up To 80%: Novo Nordisk, Pfizer And J&J Fall In Premarket ↗

May 12, 2025

What Happened: On Sunday, President Donald Trump announced on Truth Social that he plans to sign what he called the "most consequential executive order" in U.S. history, aimed at lowering prescription...

Via Benzinga

Topics Government

3 of Wall Street’s Favorite Stocks Skating on Thin Ice

May 12, 2025

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...

Via StockStory

Eli Lilly, Affirm And Regeneron Are Among Top 12 Large-Cap Losers Last Week (May 5-May 9): Are The Others In Your Portfolio? ↗

May 11, 2025

The worst performing large-cap stocks last week: ARGENX, VRTX, SMMT, MMYT, REGN, RKT, BNTX, AFRM, FNF, LLY, AUR, DASH. Any in your portfolio?

Via Benzinga

1 Cash-Heavy Stock on Our Buy List and 2 to Ignore

May 09, 2025

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining...

Via StockStory

Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. ↗

May 08, 2025

Let's have a look at the S&P500 stocks with an unusual volume in today's session.

Via Chartmill

Discover which S&P500 stocks are making waves on Thursday. ↗

May 08, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

Thursday's session: gap up and gap down stock in the S&P500 index ↗

May 08, 2025

Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

These S&P500 stocks that are showing activity before the opening bell on Thursday. ↗

May 08, 2025

Curious about the S&P500 stocks that are showing activity before the opening bell on Thursday?

Via Chartmill

Price Over Earnings Overview: Regeneron Pharmaceuticals ↗

May 07, 2025

Via Benzinga

FDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight ↗

May 06, 2025

FDA to increase surprise inspections at foreign facilities as U.S. companies pour billions into domestic drug and device manufacturing.

Via Benzinga

What's going on in today's session: S&P500 movers ↗

May 06, 2025

Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Uncover the latest developments among S&P500 stocks in today's session. ↗

May 06, 2025

Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.

Via Chartmill

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today ↗

May 05, 2025

Via Benzinga

Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday? ↗

May 05, 2025

FDA approves Teva and Alvotech's Selarsdi as an interchangeable biosimilar to Stelara, supporting the treatment of multiple chronic inflammatory diseases.

Via Benzinga

4 Dividend Stocks to Buy on the Pullback ↗

May 02, 2025

Take advantage of cheap prices

Via The Motley Fool

Regeneron to Highlight Advances at ASCO with Phase 3 Adjuvant Libtayo® (cemiplimab) CSCC Updates and Promising Early Blood Cancer Data with Linvoseltamab Combination

May 01, 2025

18 presentations across five cancer types include new insights on the potential of checkpoint inhibitors and bispecific antibodies

From Regeneron Pharmaceuticals, Inc.

Via GlobeNewswire

Dupixent® (dupilumab) Data Presented at ATS Reinforce Impact of Targeting Key Type 2 Inflammation Drivers to Improve Outcomes for Chronic Respiratory Diseases

May 01, 2025

From Regeneron Pharmaceuticals, Inc.

Via GlobeNewswire

Despite its impressive fundamentals,REGENERON PHARMACEUTICALS (NASDAQ:REGN) remains undervalued. ↗

May 01, 2025

REGENERON PHARMACEUTICALS has caught the attention as a great value stock. NASDAQ:REGN excels in profitability, solvency, and liquidity, all while being very reasonably priced.

Via Chartmill

Top S&P500 movers in Wednesday's session ↗

April 30, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.

Via Chartmill

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

62 63 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.